STZ
52
-6
AA
56
15
VRTX
47
-6
DG
8
-2
IR
63
-3
JNPR
50
-6
WU
24
4
LUV
45
-2
EXPD
43
-4
PCAR
56
-5
ED
45
3
SLG
57
-3
WMT
56
-4
MTB
65
-2
INTC
41
4
HSIC
45
5
APH
65
-3
ECL
55
-2
TSN
50
-2
ACN
47
-5
STZ
52
-6
AA
56
15
VRTX
47
-6
DG
8
-2
IR
63
-3
JNPR
50
-6
WU
24
4
LUV
45
-2
EXPD
43
-4
PCAR
56
-5
ED
45
3
SLG
57
-3
WMT
56
-4
MTB
65
-2
INTC
41
4
HSIC
45
5
APH
65
-3
ECL
55
-2
TSN
50
-2
ACN
47
-5
Financhill
Back

FibroGen Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
46

FGEN
FibroGen

Last Price:
0.33
Seasonality Move:
88.99%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
46
FibroGen (FGEN) is a Sell

Is FibroGen a Buy, Sell or Hold?

  • The current FibroGen [FGEN] share price is $0.33. The Score for FGEN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • FGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FGEN Stock Price Chart

What is FibroGen's stock price today?

  • The FibroGen share price today is $0.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FGEN is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 48.25 Sell
Chaikin Money Flow: -1403407 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.3 - 0.36) Buy
Bollinger Bands (100): (0.25 - 0.81) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.34 Sell
20-day SMA: 0.33 Buy
50-day SMA: 0.36 Sell
200-day SMA: 1.06 Sell
8-day EMA: 0.34 Sell
20-day EMA: 0.34 Sell
50-day EMA: 0.39 Sell
200-day EMA: 1.26 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

FibroGen Earnings Growth & FGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $0.48 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

FibroGen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):